QRXPHARMA LTD. Rule 3.19A.3
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/9/2001.
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of director | Michael Quinn |
Date of last notice | 29 May 2014 |
Date that director ceased to be director | 11 July 2014 |
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
75,000 Options over Ordinary Shares
+ See chapter 19 for defined terms.
11/3/2002 Appendix 3Z Page 1
Appendix 3Z Final Director's Interest Notice Part 2 - Director's relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interestNote: Provide details of the circumstances giving rise to the relevant interest
Family interests of Michael Quinn
- Kaylara Pty Ltd / Rosemary
Quinn
Innovation Capital Associates
Pty Ltd
Innovation Capital Limited
Innovation Capital LLC
Number & class of securities603,475 Ordinary Shares
5,512 Ordinary Shares
100,000 Options over Ordinary Shares
50,000 Options over Ordinary Shares
Part 3 - Director's interests in contracts
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
No. and class of securities to which interest relates | N/A |
+ See chapter 19 for defined terms.
Appendix 3Z Page 2 11/3/2002
|
distributed by
|
